Inhaled Fluticasone and Salmeterol Suppress Eosinophilic Airway Inflammation in Chronic Obstructive Pulmonary Disease: Relations with Lung Function and Bronchodilator Reversibility

By Perng Diahn-Warng   Wu Cheng-Che   Su Kang-Cheng   Lee Yu-Chin   Perng Reury-Perng   Tao Chi-Wei  

Lung, Vol. 184, Iss. 4, 2006-08 ,pp. : 217-222

Springer Publishing Company

Access to resources Recommend Favorite

AZITHROMYCIN INCREASES CHLORIDE EFFLUX FROM CYSTIC FIBROSIS AIRWAY EPITHELIAL CELLS

By Oliynyk Igor   Varelogianni Georgia   Schalling Martin   Asplund Monika Stenkvist   Roomans Godfried   Johannesson Marie  

Experimental Lung Research, Vol. 35, Iss. 3, 2009-04 ,pp. : 210-221

Informa Healthcare

Access to resources Recommend Favorite

Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes

By Anzueto Antonio   Ferguson Gary   Feldman Greg   Chinsky Kenneth   Seibert Allan   Emmett Amanda   Knobil Katharine   O'Dell Dianne   Kalberg Christopher   Crater Glenn  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 6, Iss. 5, 2009-10 ,pp. : 320-329

Informa Healthcare

Access to resources Recommend Favorite

Inhaled Salmeterol/Fluticasone Propionate Combination in Chronic Obstructive Pulmonary Disease

By Lyseng-Williamson K.A.   Keating G.M.  

American Journal of Respiratory Medicine, Vol. 1, Iss. 4, 2002-04 ,pp. : 273-282

Adis International

Access to resources Recommend Favorite

Patient-Reported Outcomes among Omalizumab and Salmeterol/Fluticasone Combination Therapy Patients

By Miller Dave   Tom Gladys   Rasouliyan Lawrence   Chipps Bradley  

Journal of Asthma, Vol. 46, Iss. 2, 2009-03 ,pp. : 179-185

Informa Healthcare

Access to resources Recommend Favorite